ClinicalTrials.Veeva

Menu

ANI and Remifentanil in Skull Pin Fixation.

K

Kaohsiung Medical University

Status and phase

Completed
Phase 4

Conditions

Pain, Procedural

Treatments

Drug: Remifentanil

Study type

Interventional

Funder types

Other

Identifiers

NCT05125328
KMUHIRB-F(I)-20210156

Details and patient eligibility

About

Forty patients were enrolled, and all patients used total intravenous anesthesia (remifentanil-propofol based total intravenous analgesia) as anesthesia induction and maintenance. According to the preliminary data of this department, patients who underwent intracranial surgery for skull pin fixation used remifentanil 5.0-6.0 ng/ml, while the hemodynamics is relatively stable. Therefore, when this plan is implemented, the patient needs to be under the same depth of anesthesia (monitored by electroencephalography, maintaining a value of 40-60), first start with remifentanil 6.0 ng/ml, and use the up and down method as adjust 0.5 ng/ml of concentration of remifentanil each time. An Analgesia Nociception Index(ANI) lower than 30 and hyperdynamics (the increased heart rate(HR) and mean blood pressure(MBP) up 20% of baseline or HR>100bpm and arterial blood pressure(ABP)>180/100mmHg) indicates insufficient analgesia, therefore increase it by 0.5 ng/ml; an ANI higher than 30 and stable hemodynamics (the changes of HR and MBP within 20% of baseline or HR<50bpm and ABP<90/50mmHg) indicates that analgesia is acceptable, and the next patient will decrease it by 0.5 ng/ml during skull pin fixation.

Data collection: Heart Rate, Measure blood pressure, Analgesia Nociception Index, Bispectral index, concentrations of propofol and remifentanil before 2 mins, during, 5, and 15 mins of skull pin fixation were recorded and analyzed.

Enrollment

27 patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Must be at least 20 years old and less than 80 years old
  2. With anesthesia risk grade below grade three (including grade three) (ASA I~III)
  3. Patients who are expected to undergo intracranial surgery for skull pin fixation

Exclusion criteria

  1. Those with anesthesia risk classification ASA class IV or higher
  2. Those who are allergic to opioid analgesics or propofol drugs
  3. Emergency patients

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

27 participants in 1 patient group

neurosurgery with fixation
Experimental group
Treatment:
Drug: Remifentanil

Trial contacts and locations

1

Loading...

Central trial contact

Zhi-Fu Wu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems